International Kidney Cancer Symposium (IKCS) 2021

The International Kidney Cancer Symposium (IKCS) 2021 took place in North America over the weekend. The following presentations are of interest to kidney cancer patients and their families and are published by UroToday: Award lecture: Dr Brian Lane gave the Andrew C. Novick Award Lecture with a talk focusing on the management of small (T1) […]

read more

First patient enrolled in renal cell carcinoma liquid biopsy trial

The first patient has been enrolled in the AURORAX-087A study involving a new liquid biopsy for the detection of recurrence after surgery for clear cell renal cell carcinoma (RCC), the most common form of kidney cancer. The study is taking place at 16 hospitals across Europe and the US, 6 of which are in the […]

read more

One Cancer Voice: Plotting a route out of the pandemic

On Saturday 9 October, the Daily Mail ran a piece from One Cancer Voice urging the government to commit much-needed funding to improve and maintain cancer services. KCSN was one of the 47 cancer charities lobbying for this change. COVID-19 has impacted cancer services and halted progress, delaying both diagnosis and treatment. Although most services […]

read more

COVID-19: Delay of third jab for extremely vulnerable

Studies have shown that people who are immunosuppressed – around 500,000 people in the UK – are unlikely to mount a strong defence against COVID-19, even after two doses of vaccine: UK vaccine booster scheme likely to start in September Do I need a booster? On 1 September, the Joint Committee on Vaccination and Immunisation […]

read more

ESMO 2021: Cancer and COVID-19: Outcomes and risk factors

This year there was some very important data presented at the ESMO 2021 virtual meeting regarding COVID-19 and cancer. We have been dealing with this pandemic for a long time, and researchers have been working hard to generate data that can inform clinical decisions regarding the outcomes and risk factors in patients with cancer and […]

read more

55,000 cancer patients miss treatment target over 6 years

Cancer Research UK has reported that over the past 6 years, almost 55,000 cancer patients have missed the 62-day wait for treatment. The key reasons for this are shortages in workforce and diagnostic equipment. These patients should have been diagnosed quicker and started treatment sooner. However, the government’s own target of 85% of cancer patients […]

read more

ESMO 2021: COVID-19 vaccine in cancer patients is comparable to the general population

The latest findings from five studies presented at the ESMO Congress 2021 help cut short the debate on the safety and efficacy of COVID vaccines in cancer patients and re-affirm ESMO’s recommendations for early vaccination of this high-priority population, as outlined in the ESMO ten statements, which were updated in April 2021. Patients with cancer or a history […]

read more

ESMO 2021: Cabozantinib for collecting duct carcinoma – the BONSAI study

Metastatic collecting duct carcinoma is an aggressive form of RCC, which is poorly researched and understood. There is an unmet need for an effective treatment for these patients, and very few clinical trials allow these patients to take part. This single centre, phase 2 trial tested cabozantinib in untreated patients with collecting duct carcinoma that […]

read more

NHS England to trial new blood test for over 50 types of cancer

NHS England is about to start a large-scale trial of a new blood test that can detect over 50 types of early stage cancer. The test is called the Galleri test, and is able to identify early signs of cancer in the blood before people start to experience symptoms. The test has been shown to […]

read more

Immunotherapy and COVID-19 in cancer patients

A recent review published in the Journal for ImmunoTherapy of Cancer looks at the implications of people with renal cell carcinoma (RCC) taking immune checkpoint inhibitors and contracting the SARS-CoV-2 virus. Cancer patients are considered at high risk during the coronavirus pandemic. However, this review states that, although additional studies are needed, the most up-to-date […]

read more
Showing 1 to 10 of 289 results
  TOP